Both in Pharmaceuticals
CAMP4 Therapeutics vs Greenwich LifeSciences
Over the past year CAMP returned −0.8% and GLSI returned +93.0%; their daily moves had a correlation of 0.21.
CAMP −0.8% GLSI +93.0%Growth of $1, one year, split-adjusted
| Metric | CAMP | GLSI |
|---|---|---|
| Price | $3.91 | $16.27 |
| Market cap | $245.4M | $238.8M |
| Today | +3.58% | −1.15% |
| 1 month | −2.5% | −3.8% |
| 6 months | −1.8% | −27.0% |
| Year to date | −36.2% | −22.6% |
| 1 year | −6.0% | +76.7% |
| Revenue growth (YoY) | +18.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −1884.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 58.2× | — |
| Net cash | $86.4M | $8.9M |
| Dividend yield | — | — |
| Volatility (60d) | 84.1% | 91.7% |
| Short % of float | 8.2% | 24.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).